arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Gossamer Bio, Inc.

GOSS

$0.18 0.00 (+1.01%) at close

10 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Gossamer Bio, Inc. faces fundamental challenges. On the positive side, Return on Common Equity (%) remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $41.1M

Dividend Yield —

Revenue Growth -57.7%

Op. Margin -352.2% ↘

ROIC 139.0% ↗

FCF / Share $-0.75 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$48.47M

↓ -57.7% —

Net Income Profit after all expenses

$-170.37M

↓ -201.4% —

Operating Margin Operating profit as % of sales

-352.2%

↓ -574.3% 0th

FCF / Share Free cash flow per share

$-0.75

↓ -4791.2% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

100

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	-57.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-822%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-200.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	78.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	56.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.4% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	11.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-201.4% Weak ↓ Weak Declining Year-over-year change in net income	68.6% Excellent ↑ Excellent Improving Year-over-year change in net income	21.6% Good ↑ Good Improving Year-over-year change in net income	2.0% Caution ↑ Caution Improving Year-over-year change in net income	3.8% Caution ↑ Caution Improving Year-over-year change in net income	-35.0% Weak ↑ Weak Improving Year-over-year change in net income	-22.7% Weak Weak Year-over-year change in net income	-2070.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-4791.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	98.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	52.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	12.9% Fair Fair Year-over-year change in free cash flow	2.0% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-352.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2448%)	-52.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-448%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	-351.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3029%)	-49.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-511%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-353.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-3.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	139.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-206.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-289.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-717.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-113.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	98.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	76.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-99.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-80.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-62.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-62.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	138.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+825%)	-191.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1378%)	-286.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2010%)	—	-192.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1384%)	-75.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-606%)	-51.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-441%)	122.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+716%)	98.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+558%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.99x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+65%)	0.24x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-60%)	0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	—	—	—
Interest Coverage (x)	-17.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.95x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-15.75x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-126.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1252.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-37.73M	$-46.07M	$-31.30M	$-99.98M	$-154.32M	$-457.31M	$-106.63M	$-105.22M	—	—
Debt / EBITDA (x)	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$0.21	$0.51	$0.00	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.75	$-0.25	$-1.18	$-2.71	$-3.13	$-3.55	—	—	—	—
Free Cash Flow per Share (USD)	$-0.75	$-0.02	$-1.04	$-2.22	$-2.54	$-2.60	—	—	—	—
Book Value per Share (USD)	$-0.53	$0.13	$0.28	$0.13	$1.60	$4.34	$5.72	$-14.91	—	—
Tangible Book Value per Share (USD)	$-0.53	$0.13	$0.28	$0.13	$1.60	$4.34	$5.72	$-14.91	—	—
Basic Weighted Avg Shares (shares)	228.52M	226.23M	152.62M	84.57M	74.84M	68.51M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$104.21M	$264.88M	$254.92M	$212.65M	$291.92M	$483.67M	$372.39M	$211.55M	—	—
LT Debt (USD)	—	$0.00	$814.00K	$11.99M	$29.08M	$28.74M	$28.46M	—	—	—
Total Equity (USD)	$-122.76M	$29.49M	$62.77M	$12.08M	$121.46M	$320.68M	$352.49M	$-120.07M	$-6.86M	$-123.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$48.47M	$114.70M	$0.00	—	—	—	—	—	—	—
Depreciation Expense (USD)	$24.00K	$833.00K	$1.61M	$1.83M	$1.74M	$1.41M	$917.00K	$297.00K	$0.00	—
Net Income, GAAP (USD)	$-170.37M	$-56.53M	$-179.82M	$-229.38M	$-234.00M	$-243.36M	$-180.31M	$-146.97M	$-6.77M	—
Operating Cash Flow (USD)	$-171.27M	$-3.47M	$-159.16M	$-187.03M	$-188.89M	$-176.36M	$-144.83M	$-51.04M	$-5.75M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters

Gossamer Bio, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GOSS with peers